Scarica l'app Stockscreener
7.54
1.34%
0.10
Dopo l'orario di chiusura:
7.58
0.04
+0.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché GRFS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$7.44
Aprire:
$7.48
Volume 24 ore:
456.29K
Relative Volume:
0.52
Capitalizzazione di mercato:
$5.12B
Reddito:
$7.57B
Utile/perdita netta:
$216.85M
Rapporto P/E:
26.14
EPS:
0.2884
Flusso di cassa netto:
$709.16M
1 W Prestazione:
-3.95%
1M Prestazione:
+5.75%
6M Prestazione:
+15.64%
1 anno Prestazione:
-31.76%
Intervallo 1D:
$7.42
$7.59
Intervallo di 1 settimana:
$7.30
$7.685
Portata 52W:
$5.3001
$11.73
Grifols Sa Adr Stock (GRFS) Company Profile
Nome
Grifols Sa Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta GRFS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRFS
Grifols Sa Adr
|
7.54 | 5.12B | 7.57B | 216.85M | 709.16M | 0.3174 |
|
LLY
Lilly Eli Co
|
778.07 | 699.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
87.52 | 388.71B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
144.02 | 346.75B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
179.44 | 317.10B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
99.17 | 250.86B | 63.17B | 12.15B | 14.84B | 4.77 |
Grifols Sa Adr Stock (GRFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-12 | Downgrade | Deutsche Bank | Hold → Sell |
| 2023-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-03-03 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-16 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2023-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-04-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-11-05 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-10-19 | Downgrade | Barclays | Overweight → Underweight |
| 2021-10-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-06-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-04-20 | Iniziato | Deutsche Bank | Hold |
| 2021-03-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-03-11 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2020-10-01 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-06-09 | Downgrade | Citigroup | Neutral → Sell |
| 2020-06-09 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2020-03-25 | Downgrade | Citigroup | Buy → Neutral |
| 2019-06-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-02-08 | Downgrade | Berenberg | Buy → Hold |
| 2018-10-11 | Aggiornamento | Berenberg | Hold → Buy |
| 2018-06-01 | Iniziato | Barclays | Overweight |
| 2017-10-31 | Iniziato | Citigroup | Buy |
| 2017-06-30 | Downgrade | Goldman | Buy → Neutral |
| 2017-04-06 | Iniziato | BofA/Merrill | Buy |
| 2017-01-03 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2016-02-09 | Aggiornamento | Berenberg | Hold → Buy |
| 2016-01-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2015-12-02 | Downgrade | HSBC Securities | Buy → Hold |
| 2015-11-20 | Downgrade | Berenberg | Buy → Hold |
| 2015-04-28 | Downgrade | Berenberg | Buy → Hold |
Mostra tutto
Grifols Sa Adr Borsa (GRFS) Ultime notizie
Grifols: More Attractive Than In A Very Long Time (NASDAQ:GRFS) - Seeking Alpha
Grifols Stock Declines After Brookfield Drops Buyout Offer - Barchart
BRF S.A. goes ex dividend tomorrow - MSN
Grifols slips as board rebuffs Brookfield’s $6.8B offer (update) - MSN
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8% - MSN
Grifols falls amid potential Moody's downgrade, new short report - MSN
Grifols stock slips as Brookfield offer rebuffed (GRFS:NASDAQ) - Seeking Alpha
Intravenous Solutions Market to Surpass USD 23.96 Billion by 2031 | SkyQuest Technology - Benzinga
Is it possible to buy Grifols SA ADR(GRFS) shares at a good price now? - US Post News
Grifols SA ADR (GRFS)’s Day in Review: Closing at 8.58, Down by -0.12 - The Dwinnex
RFID Kanban Systems Market Forecast to Reach $9.53 Billion by 2030 - GlobeNewswire Inc.
A Look at Grifols SA ADR (GRFS) Shares in the Recent Past Indicates Growth - SETE News
Cboe Global Markets Inc. (AMEX: CBOE): Getting A Free Pass? - Stocks Register
It is Poised to be a Bull Market for Grifols SA ADR (GRFS) - SETE News
Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down (NASDAQ:GRFS) - Seeking Alpha
Examining Grifols SA ADR (GRFS) stock is warranted - US Post News
Are Grifols SA ADR’shares a good deal? - US Post News
Orange To Delist From NYSE To Reduce Financial Burdens - Yahoo Finance
Financial Health Report: Grifols SA ADR (GRFS)’s Ratios Tell a Tale - The Dwinnex
Was anything negative for Grifols SA ADR (GRFS) stock last session? - US Post News
Ratio Review: Analyzing Grifols SA ADR (GRFS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
GRFS’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
How does Grifols SA ADR (GRFS) change from a tortoise to a hare? - SETE News
Mexico Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research
The Significance of Moving Averages in Grifols SA ADR Inc. (GRFS) Price Performance - The InvestChronicle
Have you been able to find a good deal on Grifols SA ADR’s shares? - US Post News
Closing Figures: Grifols SA ADR (GRFS)’s Negative Finish at 8.41, Down -1.87 - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: Grifols SA ADR (GRFS) - SETE News
Analytical Overview: Grifols SA ADR (GRFS)’s Ratios Tell a Financial Story - The Dwinnex
Investing in Grifols SA ADR (GRFS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Grifols Class B stock falls as Brookfield reportedly seeks lower price - MSN
Grifols Class B stock discounted by Brookfield (NASDAQ:GRFS) - Seeking Alpha
An analyst sees good growth prospects for Grifols SA ADR (GRFS) - SETE News
Grifols SA ADR [GRFS] Is Currently 1.11 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Grifols SA ADR (GRFS)’s Market Momentum: Closing Strong at 9.00, Up 2.74 - The Dwinnex
Grifols SA ADR (GRFS) looking to reclaim success with recent performance - SETE News
Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday - Yahoo Finance
Is the Grifols SA ADR (NASDAQ:GRFS) stock an investment opportunity? - US Post News
Get in on Grifols SA ADR’s (GRFS) buy-in window today! - SETE News
Grifols shares up on potential takeover by Brookfield - Investing.com
Market Update: Grifols SA ADR (GRFS) Sees Positive Movement, Closing at 7.18 - The Dwinnex
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
How did Grifols SA ADR (GRFS) fare last session? - US Post News
Ratios Revealed: Decoding Grifols SA ADR (GRFS)’s Financial Health - The Dwinnex
Grifols SA ADR: A Comprehensive Look at the Stock’s Ups and Downs - The InvestChronicle
Are Investors Inclined To Sell Their Bath & Body Works Inc (NYSE: BBWI) Holdings? - Stocks Register
Does Uranium Royalty Corp (NASDAQ: UROY) Still Need To Convince Analysts? - Stocks Register
What Do Wall Street Analysts Think About Tetra Technologies, Inc. (NYSE: TTI) Stock? - Stocks Register
What Did We Find About Insider Trading At Monster Beverage Corp. (NASDAQ: MNST)? - Stocks Register
The growth track for Grifols SA ADR (GRFS) has changed recently - SETE News
India Blood Transfusion Diagnostics Market Size & Outlook, 2027 - Grand View Research
Grifols Sa Adr Azioni (GRFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):